FDA Inspection 1231931 — Amoli Organics (A Division of Umedica Laboratories Pvt Ltd)
The FDA completed an inspection of Amoli Organics (A Division of Umedica Laboratories Pvt Ltd) on March 4, 2024 in Vapi. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 4, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Vapi (India)